Hiroko Maeda
Impact in
- Biochemistry top 10%
- Phytochemicals and Antioxidant Activities
-
- Mercury impact and mitigation studies
- Heavy Metal Exposure and Toxicity
Papers in
-
- Monoclonal and Polyclonal Antibodies Research 3
-
- Plant-based Medicinal Research 2
- Co-authors
- Yusuke Sakata (2 shared papers)Keiichi Shimizu (2 shared papers)Fumio Hashimoto (2 shared papers)Casey Todd Weaver (1 shared paper)Richard D. Hockett (1 shared paper)Arman Saparov (1 shared paper)James R. Oliver (1 shared paper)Rui Zheng (1 shared paper)
- Journals
- Journal of the Neurological Sciences (1 paper)Journal of Vascular and Interventional Radiology (1 paper)American Journal of Roentgenology (1 paper)Bioscience Biotechnology and Biochemistry (1 paper)Toxicology and Applied Pharmacology (1 paper)
- Partner nations
- JapanUnited StatesNetherlands
In The Last Decade
Hiroko Maeda
26 papers receiving 434 citations
Peers
Comparison fields: 5 of 87
- Biochemistry 49
- Health, Toxicology and Mutagenesis 85
- Nutrition and Dietetics 70
- Immunology 90
- Chemical Health and Safety 2
Countries citing papers authored by Hiroko Maeda
This map shows the geographic impact of Hiroko Maeda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroko Maeda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroko Maeda more than expected).
Fields of papers citing papers by Hiroko Maeda
This network shows the impact of papers produced by Hiroko Maeda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroko Maeda. The network helps show where Hiroko Maeda may publish in the future.
Co-authors
The 25 scholars most cited alongside Hiroko Maeda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 92 | |
| 2 | 1975 | 63 | |
| 3 | 2000 | 43 | |
| 4 | 1991 | 36 | |
| 5 | 2002 | 30 | |
| 6 | 2009 | 30 | |
| 7 | 1999 | 22 | |
| 8 | 1996 | 19 | |
| 9 | 1975 | 19 | |
| 10 | 2013 | 16 | |
| 11 | 1983 | 16 | |
| 12 | 1989 | 14 | |
| 13 | 1999 | 11 | |
| 14 | 1992 | 10 | |
| 15 | 1991 | 9 | |
| 16 | 1982 | 9 | |
| 17 | 1994 | 7 | |
| 18 | [The mutagenicity evaluation of MT-141, a new cephamycin]. | 1984 | 3 |
| 19 | The Little Data Book on Gender 2019 | 2019 | 3 |
| 20 | 1994 | 3 |
About Hiroko Maeda
Hiroko Maeda is a scholar working on Radiology, Nuclear Medicine and Imaging, Pharmacology, Food Science, Oncology and Immunology, having authored 28 papers that have together received 463 indexed citations. Recurring topics across this work include Glycosylation and Glycoproteins Research (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Botanical Research and Applications (2 papers), Selenium in Biological Systems (2 papers), Mitochondrial Function and Pathology (2 papers), Global Maternal and Child Health (2 papers), Plant-based Medicinal Research (2 papers) and Mercury impact and mitigation studies (2 papers). The work is most often cited by research in Biochemistry (49 citations), Health, Toxicology and Mutagenesis (85 citations), Nutrition and Dietetics (70 citations), Immunology (90 citations) and Chemical Health and Safety (2 citations). Hiroko Maeda has collaborated with scholars based in Japan, United States and Netherlands. Frequent co-authors include Yusuke Sakata, Keiichi Shimizu, Fumio Hashimoto, Casey Todd Weaver, Richard D. Hockett, Arman Saparov, James R. Oliver, Rui Zheng, Gen Ohi and Hironobu Seki. Their work appears in journals such as Journal of the Neurological Sciences, Journal of Vascular and Interventional Radiology, American Journal of Roentgenology, Bioscience Biotechnology and Biochemistry and Toxicology and Applied Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.